50/50 Release 24 HR methylphenidate hydrochloride 60 MG Extended Release Oral Capsule — RxCUI 1806185
RxNorm drug concept · Semantic clinical drug
RxCUI 1806185
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
12 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1806185
Official name50/50 Release 24 HR methylphenidate hydrochloride 60 MG Extended Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmethylphenidate HCl 60 MG 50/50 Release 24HR Extended Release Oral Capsule
FDA products mapped12
Package NDCs mapped12
Reported Medicaid activity (SDUD)154,879 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Methylphenidate Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Yes, location matters. Apply the patch to the hip area — not the waist, arm, or back. The clinical studies that established how well and how safely the patch works were done specif...
- Where exactly do I put the patch and does it matter?
- Water exposure — from bathing, swimming, or showering — can affect how well the patch sticks. If the patch partially or fully comes off, don't try to re-stick it with tape or adhes...
- Can my child shower or swim while wearing the patch?
🕸️ Concept Web — How 50/50 Release 24 HR methylphenidate hydrochlorid... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
50/50 Release 24 HR methylphenidate hydrochloride 60 MG Extended Release Oral Capsule
RxCUI 1806185 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Methylphenidate
6901IN -
Methylphenidate hydrochloride
203188PIN
-
Methylphenidate
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Methylphenidate Extended Release Oral Capsule
374655SCDF -
Methylphenidate hydrochloride Extended Release Oral Capsule
2647476SCDFP -
Methylphenidate Oral Product
1163482SCDG -
Methylphenidate Pill
1163483SCDG -
Methylphenidate hydrochloride Oral Product
2661865SCDGP -
Methylphenidate hydrochloride Pill
2659123SCDGP -
Extended Release Oral Capsule
316943DF -
Oral Product
1151131DFG - +1 more in this family
-
Methylphenidate Extended Release Oral Capsule
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Methylphenidate hydrochloride 60 MG
1091217SCDC
-
Methylphenidate hydrochloride 60 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Methylphenidate hydrochloride 60 MG
SCDC · 1091217 -
Methylphenidate Extended Release Oral Capsule
SCDF · 374655 -
Methylphenidate hydrochloride Extended Release Oral Capsule
SCDFP · 2647476 -
Methylphenidate Oral Product
SCDG · 1163482 -
Methylphenidate Pill
SCDG · 1163483 -
Methylphenidate hydrochloride Oral Product
SCDGP · 2661865 -
Methylphenidate hydrochloride Pill
SCDGP · 2659123
📦 FDA Products & Package NDCs
12 products · 12 package NDCs
12 package NDCs map to RxCUI 1806185 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 51862-0611-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51862-61... | Methylphenidate Hydrochloride (LA) | Mayne Pharma | 2019-06-10 |
| 51862-0612-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51862-61... | Methylphenidate Hydrochloride (LA) | Mayne Pharma | 2019-06-10 |
| 70010-0012-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70010-012-01) | Methylphenidate Hydrochloride | Granules Pharmaceuticals Inc. | 2019-09-10 |
| 70010-0013-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70010-013-01) | Methylphenidate Hydrochloride | Granules Pharmaceuticals Inc. | 2019-09-10 |
| 70010-0014-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70010-014-01) | Methylphenidate Hydrochloride | Granules Pharmaceuticals Inc. | 2019-09-10 |
| 70010-0015-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70010-015-01) | Methylphenidate Hydrochloride | Granules Pharmaceuticals Inc. | 2019-09-10 |
| 70010-0016-03 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70010-016-03) | Methylphenidate Hydrochloride | Granules Pharmaceuticals Inc. | 2019-09-10 |
| 75907-0049-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (75907-04... | Methylphenidate Hydrochloride (LA) | Dr. Reddy's Laboratories Inc | 2024-12-20 |
| 75907-0050-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (75907-05... | Methylphenidate Hydrochloride (LA) | Dr. Reddy's Laboratories Inc | 2024-12-20 |
| 75907-0051-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (75907-05... | Methylphenidate Hydrochloride (LA) | Dr. Reddy's Laboratories Inc | 2024-12-20 |
| 75907-0052-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (75907-05... | Methylphenidate Hydrochloride (LA) | Dr. Reddy's Laboratories Inc | 2024-12-20 |
| 75907-0053-30 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (75907-053... | Methylphenidate Hydrochloride (LA) | Dr. Reddy's Laboratories Inc | 2024-12-20 |
Observed labelers:
Dr. Reddy's Laboratories Inc (5) ·
Granules Pharmaceuticals Inc. (5) ·
Mayne Pharma (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.